Clinical trials involving volunteers aged 18 to 60 are said to be underway to test the first pill designed by Pfizer Laboratory to defeat the SARS-CoV-2 corona virus, especially in Belgium and the United States. If the treatment proves successful, the availability of this solution by the end of 2021 can be confirmed.
Last week, the British government announced the establishment of “specialized work units” focusing on antiviral solutions to determine the potential investment in such drugs.
A new type of treatment: treatment rather than prevention
This will be the first in the fight against the virus: after one of the first vaccines using the revolutionary messenger RNA technique has already been introduced to the market, US labs may again hit Pfizer hard.
Unlike vaccine serum, which should be used as a preventive measure before any Govt-19 infection, a medical pill can be taken as soon as the first symptoms appear.
Scientists believe that the molecule used in the tablet will directly attack the “backbone” of the infection, preventing it from growing in our nose, throat or even our lungs. The same type of molecule has been shown to prevent the spread of other viruses, such as HIV or hepatitis C.
Boris Johnson announced a few days ago that “learning to live with this disease is essential.” In this sense, he believes, with his specialized antiviral work units, it is possible to provide British pills to treat Covid-19 this fall, with the goal of getting as many hospitals as possible.